SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA Approves Regeneron’s Livsayis for AChR-Positive Generalized Myasthenia Gravis

The FDA approved Livsayis (cemdisiran) for adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.

REGN

Related stories